Overview

Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Miltefosine (longer course) will be used to try to improve the cure rate of mucosal leishmaniasis
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
AB Foundation
Treatments:
Miltefosine